Finance

Lists
Why is TLIK down 14.74%?
Dive Deeper
TLIK:FRA
Arzneiwerk VIDA AG
€ 0.16
-14.74%
(-0.028) 1D
10-р сарын 9, 08:23:20 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for TLIK...
Open
€ 0.16
High
€ 0.16
Low
€ 0.16
Mkt. cap
1.03 сая
Avg. vol.
1.00 мян.
Volume
2.00 мян
52-wk high
€ 0.59
52-wk low
€ 0.00
EPS
-€ 0.09
No. of employees
1
Open
€ 0.16
High
€ 0.16
Low
€ 0.16
Mkt. cap
1.03 сая
Avg. vol.
1.00 мян.
Volume
2.00 мян
52-wk high
€ 0.59
52-wk low
€ 0.00
EPS
-€ 0.09
No. of employees
1
News stories
From web sources and news partners
Profile
TELES AG Informationstechnologien is a provider of equipment and services to fixed, fixed-mobile convergence, and Next Generation Networking service providers. The company was founded in 1983 as TELES GmbH by Professor Dr.-Ing. Sigram Schindler in close cooperation with Technische Universität Berlin. Professor Schindler lectured in telecommunications at the university until 1998. In 1997, he was voted High-Tech Manager of the Year by Manager Magazine in Germany. Active in VoIP technology development since 1996, the company's main development and operational focus lies in the areas of IMS and NGN. TELES supplies service providers with complete Class 4 and Class 5 NGN Softswitch. TELES NGN is a standard based, scalable architecture aimed at minimizing integration time and allowing quick deployment. It includes hosted voice functionality which enables residential VoIP services, hosted PBX services, Fixed-Mobile-Convergence, IP Trunking, and additional value added applications. Classical NGN/PSTN applications like Wholesale, Long Distance, and NGN backbone services are also available with this. Wikipedia
About Arzneiwerk VIDA AG
CEOOliver Olbrich
Employees1
Founded1983
Headquarters-
SectorHealth care provider
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-935.00
1.03 мян
100.00
300.00
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.36 мян
20.36 мян
12.21 мян
6.64 мян
Operating expense
105.46 мян
-132.85 мян
3.22 мян
50.95 мян
Total operating expenses
105.46 мян
-132.85 мян
3.22 мян
50.95 мян
Operating income
-106.39 мян
133.88 мян
-3.12 мян
-50.65 мян
Other non operating income
1.00
-81.53 мян
-
-1.00
EBT including unusual items
-173.94 мян
92.52 мян
-75.99 мян
-125.68 мян
EBT excluding unusual items
-173.94 мян
57.82 мян
-75.99 мян
-125.68 мян
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
83.79 мян
-153.53 мян
-9.27 мян
44.18 мян
Net income
-173.94 мян
92.52 мян
-75.99 мян
-125.68 мян
Net profit margin
18,603.64%
9,017.54%
-75,993.00%
-41,895.00%
Earnings per share
-
-
-
-
Interest and investment income
-
5.47 мян
-
-
Interest expense
-67.55 мян
-
-72.88 мян
-75.03 мян
Net interest expenses
-67.55 мян
5.47 мян
-72.88 мян
-75.03 мян
Depreciation and amortization charges
316.00
316.00
282.00
132.00
EBITDA
-106.08 мян
134.19 мян
-2.84 мян
-50.52 мян
Gain or loss from assets sale
-
-
-
1.79 мян
AI content may include mistakes. Learn more
Google аппс